Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Stock Short Interest Jumps 170.8%

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totaling 65 shares, an increase of 170.8% from the September 15th total of 24 shares. Based on an average daily trading volume, of 1,647 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

Innovator IBD Breakout Opportunities ETF Stock Down 1.1%

Shares of BOUT traded down $0.45 during mid-day trading on Tuesday, hitting $42.31. 831 shares of the company’s stock traded hands, compared to its average volume of 3,549. The business’s 50-day moving average price is $44.13 and its 200-day moving average price is $44.95. Innovator IBD Breakout Opportunities ETF has a 1 year low of $35.05 and a 1 year high of $49.41. The firm has a market capitalization of $14.81 million, a P/E ratio of 28.69 and a beta of 1.04.

Innovator IBD Breakout Opportunities ETF Company Profile

(Get Free Report)

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.

Recommended Stories

Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.